Search Results for “” – Page 28 – OSLM

OSLM

Outcome Studies
in Laboratory Medicine

guest

👤

Learn more about this platform

Categories:Observational Change patient management

403 Publications found

DPYD genotype-guided dose individualisation of fluoropyrimidine therapy in patients with cancer: a prospective safety analysis.

b

The Lancet. Oncology

November 1, 2018

p Pharmacogenetic and Pharmacogenomics

c Change patient management Highlighted Observational Safety
Delivering Precision Oncology in a Community Cancer Program: Results From a Prospective Observational Study.

b

JCO precision oncology

November 1, 2018

p Cancer

c Change patient management Observational
The impact of blood culture identification by MALDI-TOF MS on the antimicrobial management of pediatric patients.

b

Diagnostic microbiology and infectious disease

November 1, 2018

p MALDI-TOF MS For Microorganism Identification

c Change patient management Clinical outcomes Observational Operational efficiencies
Association of Time in Range, as Assessed by Continuous Glucose Monitoring, With Diabetic Retinopathy in Type 2 Diabetes.

b

Diabetes care

November 1, 2018

p Diabetes

c Change patient management Observational
Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative.

b

Clinical cancer research : an official journal of the American Association for Cancer Research

October 15, 2018

p Cancer

c Change patient management Clinical outcomes Highlighted Observational
A clinical evaluation of placental growth factor in routine practice in high-risk women presenting with suspected pre-eclampsia and/or fetal growth restriction.

b

Pregnancy hypertension

October 1, 2018

p Preeclampsia

c Change patient management Highlighted Observational
Placental Growth Factor informed management of suspected pre-eclampsia or fetal growth restriction: The MAPPLE cohort study.

b

Pregnancy hypertension

October 1, 2018

p Preeclampsia

c Change patient management Clinical outcomes Highlighted Observational
Detection of EGFR mutations in plasma circulating tumour DNA as a selection criterion for first-line gefitinib treatment in patients with advanced lung adenocarcinoma (BENEFIT): a phase 2, single-arm, multicentre clinical trial.

b

The Lancet. Respiratory medicine

September 1, 2018

p Cancer

c Change patient management Clinical outcomes Observational
Therapeutic Drug Monitoring is More Cost-Effective than a Clinically Based Approach in the Management of Loss of Response to Infliximab in Inflammatory Bowel Disease: An Observational Multicentre Study.

b

Journal of Crohn's & colitis

August 29, 2018

p Therapeutic drug monitoring

c Change patient management Clinical outcomes Observational Operational efficiencies
Significant Patient Impact Observed Upon Implementation of Point-of-Care Early Infant Diagnosis Technologies in an Observational Study in Malawi.

b

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

August 16, 2018

p HIV POCT

c Change patient management Highlighted Observational